Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients

NCT00622089 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

150

Enrollment

INDUSTRY

Sponsor class

Stopped Program terminated

Conditions

Type 2 Diabetes

Interventions

DRUG: DIO-902
DRUG: DIO-902
DRUG: DIO-902

Sponsor

DiObex